Layoffs at X4 Pharmaceuticals
- Layoff events
- 2
- verified and sourced
- Roles reported
- At least 43
- events with no figure are not in this number
- Announced between
- Feb 2025 to Sep 2025
- Reported by
- U.S. Securities and Exchange Commission and X4 Pharmaceuticals
This page records what we could verify and source. It is not a complete record of every job cut at X4 Pharmaceuticals: a layoff nobody published and nobody sent us is a layoff that is not on this page.
| Company | What happened | Roles reported | Share of staff | Where | Announced | Sources |
|---|---|---|---|---|---|---|
| X4 Pharmaceuticals |
Restructuring
X4 Pharmaceuticals announced an additional restructuring that would reduce its workforce by approximately 50% to focus resources on completing the 4WARD phase 3 trial. |
Not known | 50% | Company-wide |
2 sources for X4 Pharmaceuticals |
|
| X4 Pharmaceuticals |
Restructuring
X4 Pharmaceuticals announced a strategic restructuring that would reduce employee headcount by 43 and close its Vienna facility while concentrating resources on mavorixafor. |
43 | Not known | Company-wide |
1 source for X4 Pharmaceuticals |
Where this comes from
Every cut listed for X4 Pharmaceuticals was entered by a person who checked it against a filing or a named report. Nothing is scraped and nothing publishes itself. What is not here is what we have not verified, not what did not happen.
Spotted something wrong or missing about X4 Pharmaceuticals? Tell us on our Discord and we will check it.